BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14609224)

  • 1. Notch signalling in the peripheral immune system.
    Dallman MJ; Champion B; Lamb JR
    Novartis Found Symp; 2003; 252():268-76; discussion 276-8. PubMed ID: 14609224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch1 co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production.
    Benson RA; Adamson K; Corsin-Jimenez M; Marley JV; Wahl KA; Lamb JR; Howie SE
    Eur J Immunol; 2005 Mar; 35(3):859-69. PubMed ID: 15688350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch: control of lymphocyte differentiation in the periphery.
    Dallman MJ; Smith E; Benson RA; Lamb JR
    Curr Opin Immunol; 2005 Jun; 17(3):259-66. PubMed ID: 15886115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions.
    Schmitt TM; Ciofani M; Petrie HT; Zúñiga-Pflücker JC
    J Exp Med; 2004 Aug; 200(4):469-79. PubMed ID: 15314075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Notch and Sonic hedgehog signalling pathways in immunity.
    Benson RA; Lowrey JA; Lamb JR; Howie SE
    Mol Immunol; 2004 Jul; 41(6-7):715-25. PubMed ID: 15220006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells and mechanisms of immune system control.
    O'Garra A; Vieira P
    Nat Med; 2004 Aug; 10(8):801-5. PubMed ID: 15286781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling in lymphocyte development and function.
    Robey EA; Bluestone JA
    Curr Opin Immunol; 2004 Jun; 16(3):360-6. PubMed ID: 15134786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid raft domains and protein networks in T-cell receptor signal transduction.
    Harder T
    Curr Opin Immunol; 2004 Jun; 16(3):353-9. PubMed ID: 15134785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch regulation of lymphocyte development and function.
    Radtke F; Wilson A; Mancini SJ; MacDonald HR
    Nat Immunol; 2004 Mar; 5(3):247-53. PubMed ID: 14985712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell signalling and immune system disorders.
    Wilkinson B; Downey JS; Rudd CE
    Expert Rev Mol Med; 2005 Dec; 7(29):1-29. PubMed ID: 16364187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
    Jiang S; Herrera O; Lechler RI
    Curr Opin Immunol; 2004 Oct; 16(5):550-7. PubMed ID: 15341998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of auxiliary signals to T cells as a mechanism to induce transplant tolerance.
    Gorczynski RM
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):91-101. PubMed ID: 15928578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance.
    Jiang X; Morita M; Sugioka A; Harada M; Kojo S; Wakao H; Watarai H; Ohkohchi N; Taniguchi M; Seino K
    Liver Transpl; 2006 Jul; 12(7):1112-8. PubMed ID: 16724335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance.
    Watte CM; Nakamura T; Lau CH; Ortaldo JR; Stein-Streilein J
    J Leukoc Biol; 2008 Apr; 83(4):928-35. PubMed ID: 18192489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.